New mastitis study shows the importance of treating gram-positive infections

Dairy Producers Can Increase Milk Production While Reducing Mastitis, Number of Treatments, Antibiotic Costs and Milk Discard
Mastitis treatment protocols are supported by results of a new three-year, multi-university study, which showed a striking 91% of detected intramammary infections (IMI) were caused by gram-positive pathogens, including both environmental and contagious organisms. A small number of IMI infections were caused by gram-negative pathogens, including E. coli.

The findings, presented at this year’s National Mastitis Council annual meeting, bring new clarity to the value of aggressively treating gram-positive infections with proven antibiotics, while leaving gram-negative infections to self-cure without treatment.

“Mastitis remains the most costly disease and the most common reason antibiotics are used on U.S. dairy farms,” says Dave Juda, director of marketing – livestock and equine, Fort Dodge Animal Health. “Early intervention strategies focused on gram-positive infections can provide significant savings to dairy producers by reducing antibiotic costs, reducing the number of mastitis treatments and reducing milk discard.”

Clinical and subclinical IMI infections can be effectively treated with a broad-spectrum antibiotic with high efficacy against gram-positive pathogens, such as Fort Dodge Animal Health’s ToDAY® (cephapirin sodium) and ToMORROW® (cephapirin benzathine). 

ToDAY provides a bacteriological cure rate of more than 80%, at the labeled dose for gram-positive infections with just one day of treatment. Unlike many other antibiotics, ToDAY and ToMORROW are labeled to control penicillin-resistant strains of Staph. Aureus, which comprises 43% of contagious mastitis pathogens. The OPTI-SERT partial insertion tip has been shown to reduce new mastitis infections by up to 50%.
Fort Dodge Animal Health is a leading global manufacturer and marketer of animal health products for dairy, beef, swine, ovine, poultry, equine and companion animal industries. Key dairy products include ToDAY, ToMORROW, Dry-Clox® (cloxacillin benzathine), Triangle® Vaccines, PYRAMID® Vaccines, Presponse® Vaccines, Cydectin® Pour-On and Cydectin® Injectable.